FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kappel, C. A.
Right arrow Articles by Jay, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kappel, C. A.
Right arrow Articles by Jay, G.

The FASEB Journal, Vol 8, 583-592, Copyright © 1994 by The Federation of American Societies for Experimental Biology


REVIEWS

Evolving concepts in molecular pathology

CA Kappel, CJ Bieberich and G Jay
Department of Virology, Jerome H. Holland Laboratory, Rockville, Maryland 20855.

During the last decade, an understanding of the causes of many human diseases has progressed rapidly, in large measure because of the development of technologies that allow us to identify the genes that are involved. Identification of a gene that is suspected to play an important role in a particular disease opens up a whole new dimension of research to understand the molecular events that underlie the cause of that disorder. A crucial step in this process is often the development of an animal model of the disease. Again, the last decade has seen rapid advances in our ability to create such models, particularly in mice. Technologies that allow for the addition, alteration, or elimination of individual genes from the genome to create a transgenic mouse are now routine. The advantages of having a transgenic mouse model of a human disease are many. These animals often provide the first unequivocal proof that a particular gene is responsible for causing the pathological changes that occur with disease. They also can provide a system to carefully dissect the successive events that lead to the disease state, and can provide a custom-designed whole animal system to test potential therapies to treat and eventually cure the disease. Most important, new concepts relating to gene expression and gene function in disease often emerge from such transgenic studies. This review will illustrate several examples in which transgenic animals have contributed significantly to the evolution of concepts of the underlying mechanisms of human disease.


This article has been cited by other articles:


Home page
Toxicol PatholHome page
N. A. Gillett and C. M. Chan
Molecular Pathology in the Preclinical Development of Biopharmaceuticals
Toxicol Pathol, January 1, 1999; 27(1): 48 - 52.
[Abstract] [PDF]


Home page
HypertensionHome page
P. Wiesel, L. Mazzolai, J. Nussberger, and T. Pedrazzini
Two-Kidney, One Clip and One-Kidney, One Clip Hypertension in Mice
Hypertension, April 1, 1997; 29(4): 1025 - 1030.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by The Federation of American Societies for Experimental Biology.